Virtual Podium: Biomarkers for Lupus Diagnosis and Disease Activity

Watch Dr. Michael Ward, investigator with the intramural research program for the National Institute of Arthritis and Musculoskeletal and Skin Diseases present a review of biomarkers used or being evaluated to diagnose lupus and monitor disease activity during the Ninth International Congress on Lupus in Vancouver, British Columbia.

The Lupus Foundation of America has advocated to expand federal funding and also has supported research studies through its National Research Program to validate lupus biomarkers. Validated biomarkers are essential to having the tools needed to improve the diagnosis and treatment of lupus, develop screening tests for the disease, and speed development and approval of new, safe and more tolerable therapies for lupus.

*Video Produced by The Lupus Foundation of America

Subscribe for updates


See how we apply our specialized large molecule expertise to help solve your bioanalytical challenges.

View Services

Analytical Assays Determine Biosimilar Product Quality


Pharmacokinetics & Pharmacodynamics​

See how our PK expertise complements our immunogenicity services by evaluating absorption, distribution, metabolism and excretion characteristics of a product.
220328 Adleverage_Scientific Icon Illustrations_#46-65_CO_Per FIles